Vasso Apostolopoulos, PhD Professor

Email: vasso@scientist.com

     Vasso Apostolopoulos - Presentations
Website Designed by www.SevenStarWebsites.com™  Copyright ©  2011-2014
ORAL PRESENTATIONS AT MEETINGS / CONFERENCES

​2014

Plenary Speaker (invited, April 2014). 15th International Conference in Medicinal Chemistry: Drug Discovery and Design, Conference. University of Patras, Dept of Chemistry and Pharmacology. Patras, Greece.
Development of an ovarian / breast cancer vaccine: what have we learnt in the last 20 years


2012

Invited Speaker. 32nd European Peptide Symposium (could not attend), Athens Greece
Peptides as therapeutic agents in disease


2011

Platform Presentation. Progress in MS Research. Melbourne VIC Australia
Immunotherapeutic aspects for MS: are we heading in the right direction..?


2010

Invited Speaker. Synergy Symposium: Blood Diseases and Cancer, Monash University, Department of Immunology, Alfred Medical Research and Education Precinct (AMREP), Prahran, VIC Australia.
12 years follow-up of patients immunised with mannan-MUC1

Invited Speaker. Melbourne Human Immunology Meeting, AMREP, Prahran, Melbourne, VIC Australia.
12 years follow-up of early breast cancer patients immunised with mannan-MUC1


​2008

Keynote Speaker (invited). 1st International Conference on Drug Design and Discovery, Dubai, UAE.
Peptide based vaccines: A structural and immunological perspective.

Plenary Lecture (invited). 9th International Conference in Medicinal Chemistry: Drug Discovery and Design, Conference. University of Patras, Dept of Chemistry and Pharmacology. Patras, Greece. 
Mannosylated antigens induces potent immune responses in vivo

Invited Speaker. 2nd Australasian vaccines and immunotherapeutics development (AVID) meeting. Surfers Paradise, Queensland Australia. 
Orphan vaccines: MUC1 Vaccine


​2007

Plenary Lecture (invited). 8th International Conference in Medicinal Chemistry: Drug Discovery and Design, Conference. University of Patras, Dept of Chemistry and Pharmacology. Patras, Greece. 
MUC1 cancer immunotherapy: what have we learnt in the last 15 years.

Speaker (invited). 9th Annual DC Symposium, DC Immunotherapy. Mater Medical Research Institute, Brisbane, Qld, Australia
Antigen delivery to dendritic cells in vivo and ex vivo using mannan and penetratin

Symposium Session Speaker. Mucins in Health and Disease: 9th International Workshop on carcinoma-associated mucins. (Session: Vaccines) Robinsons College, Cambridge, UK.
Novel modes of peptide-MHC interactions – improving peptide based vaccines

Plenary Lecture (invited, could not attend). 12th World Congress on Advances in Oncology and
 10th International Symposium on Molecular Medicine, Creta Maris, Hersonissos, Crete, Greece
Progress in Cancer immunotherapy


2006

Plenary Lecture (invited). 7th International Conference in Medicinal Chemistry: Drug Discovery and Design, Conference. University of Patras, Dept of Chemistry and Pharmacology. Patras, Greece. 
Cancer Immunotherapy: past, present, future.

Speaker (invited). 1st Australasian vaccines and immunotherapeutics development (AVID) meeting. Bio21 Molecular Science and Biotechnology Institute, VIC Australia. 
Pilot Phase III immunotherapy study in early stage breast cancer patients using oxidized mannan-MUC1

Speaker (invited). 1st Women’s Wellness in the West Conference. Victoria University Convention Centre, Australia. 
Breast cancer research – past, present and where are we heading

Speaker. 3rd Australian Health Medical Research Congress. Clinical Oncological Society of Australia. Melbourne, Australia. 
Human clinical trials: Oxidised mannan-MUC1 in Pilot Phase III immunotherapy study in early stage breast cancer patients

Symposium Session Speaker, Antigen Presentation. 36th Australasian Society for Immunology. Auckland, New Zealand
Non canonical peptide complexes with MHC class I or II: are we seeing the whole picture 


​2005

Symposium Session Speaker, Antigen Presentation (invited). 35th Australasian Society for Immunology. Melbourne Australia
New modes of peptide binding to MHC molecules.

Plenary Lecture (invited). Mucins in Health and Disease: 8th International Workshop on carcinoma-associated mucins. Robinsons College, Cambridge, UK.
Structural and immunological analysis of non-canonical peptide complexes with MHC class I: new approaches to vaccine design.

Plenary Lecture (invited). 14th Cancer Research Institute Symposium – Cancer Immunology and Immunotherapy. Seoul National University College of Medicine, Seoul, Korea. 
MUC1 cancer Vaccine: From animal models to human clinical trials

Plenary Lecture (invited, could not attend). 6th International Conference in Medicinal Chemistry: Drug Discovery and Design, Conference. University of Patras, Dept Chemistry Pharmacology. Patras, Greece.

Plenary Lecture (invited, could not attend). 8th International Conference on Gene and drug therapy. Crete, Greece.


2004

Speaker. Tumour Immunology Workshop, 34th Australian Society for Immunology, Adelaide SA Australia
Structural and immunological analysis of non-canonical peptide complexes with MHC class I: new approaches to vaccine design.

Plenary Lectures (invited). 5th International Conference in Medicinal Chemistry: Drug Discovery and Design, Conference. University of Patras, Dept of Chemistry and Pharmacology. Patras, Greece. 
i) Results of a pilot phase III clinical trial using mannan-MUC1 in cancer therapy and of a phase I/II clinical trial using ex-vivo cultured dendritic cells pulsed with mannan-MUC1
ii) Peptide MHC class I crystal structures: new methods of peptide based vaccine design

Plenary Lecture (invited, could not attend). Tumour Immunity Symposium. Seoul National University College of Medicine, Seoul, Korea

Plenary Lecture (invited). 7th International Conference of Anticancer Research, Corfu, Greece.


2003

Plenary Lecture (invited, could not attend). 4th Medicinal Chemistry: Drug Discovery and Design, Conference. University of Patras, Departments of Chemistry and Pharmacology. Patras, Greece.


2002

Plenary Lecture (invited). 3rd International Conference in Medicinal Chemistry: Drug Discovery and Design, Conference. University of Patras, Dept of Chemistry and Pharmacology. Patras, Greece
Crystal structures of non-canonical low & high affinity peptide complexes with MHC class I: a novel use of alternative anchors

Symposium Lectures (invited). 3rd International Conference in Medicinal Chemistry: Drug Discovery and Design, Conference. University of Patras, Dept of Chemistry and Pharmacology. Patras, Greece
Update on clinical trials in adenocarcinoma patients immunised with mannan-MUC1

Keynote Speaker (invited). 7th National Disability & Absence Management Conference, San Antonio, Texas, USA
Breakthroughs in Cancer Research - Where are we heading


2001

Speaker. West Coast Protein Crystallography Workshop. Pacific Grove, CA USA.
Crystal Structures of Non Canonical Binding Peptides: Low Affinity Vs High Affinity Binding

Workshop Speaker. 31st Australasian Society for Immunology, Canberra, Australia.
Crystal structure of a non-canonical low affinity peptide complexed with MHC class I

Symposium Speaker. Tumour Immunology Workshop - 31st Australasian Society for Immunology, Canberra Australia 
Crystal structure of a non-canonical high affinity peptide complexed with MHC class I: a novel use of alternative anchors.

Plenary Lecture (invited). 2nd International Conference in Medicinal Chemistry: Drug Discovery and Design, Conference. University of Patras, Dept of Chemistry and Pharmacy. Patras, Greece.
Crystal structure of a non-canonical low affinity peptide bound to MHC class I: implications for tumour immunotherapy.


2000

Keystone Symposia. Molecular and Cellular Biology. Cellular Immunity & Immunotherapy of Cancer. Santa Fe New Mexico USA
Novel features of peptide binding to MHC Class I molecules

Plenary Lecture (invited). 1st International Conference in Medicinal Chemistry: Drug Discovery and Design Conference. University of Patras, Dept of Chemistry and Pharmacology. Patras, Greece
Structural implications for the design of molecular vaccines in the immunotherapy of cancer

Speaker. 26th Annual Conference of La Jolla Immunologists. Salk Institute, La Jolla CA USA
Crystal structure of an immunogenic peptide-MHC complex with a non-canonical low affinity peptide

Speaker. 4th Annual Fall Research Symposium of the Society of Fellows. The Scripps Research Institute, La Jolla CA USA
Crystal structure of an immunogenic peptide-MHC complex with a non-canonical low affinity peptide


1999

Speaker. West Coast Protein Crystallography Workshop. Pacific Grove, CA USA
Unusual and novel features of peptide binding to MHC Class I molecules

Invited Speaker. Annual American Mensa Conference. Long Beach, CA, USA. 
Cancer Research: Past, Present and Future

Keynote Speaker (invited). 40th Convention, Pan-Arcadian Federation of America, Anaheim, CA USA. 
Cancer Research in the next decade


1998

Symposia Speaker (invited). International Symposium. Advances Peptide Protein Nucleic Acid Vaccine Strategies, Oxford England
Mimics and cross reactions of relevance to tumour immunotherapy

Speaker. 5th International Workshop - Carcinoma Associated Mucins, Cambridge, England
The mode of intracellular transport and trafficking of MUC1 peptides

Speaker (invited). 24th Annual Conference of La Jolla Immunologists. Salk Institute La Jolla CA USA
Determination of MHC class II T cell epitopes with peptide libraries

Speaker (invited). 24th Annual Conference of La Jolla Immunologists. Salk Institute La Jolla CA USA
Functional characterization of a recombinant murine I-Ag7 molecule

Keynote Speaker (invited). Peptides and Peptide Mimetics, Drug Discovery and Design, Workshop. University of Patras, Department of Chemistry, Patras, Greece.
i) Peptide mimics for tumour immunotherapy
ii) Summary of pre-clinical and clinical studies using mannan-MUC1


​1997

Speaker (invited). Vaccine Strategies, European Mucin Immunology Group, San Miniato, Italy
i) Peptide mimics for cancer therapy
ii) Mouse models for Class I restricted responses
iii) Results of Trials from the Austin Research Institute

Symposia Speaker. Tumour Immunology. 27th Annual Scientific meeting, Australian Society for Immunology, Perth WA, Australia
Mimics and cross reactions of relevance to tumour immunotherapy

Workshop Speaker. Antigen Processing & Presentation Session. 2nd Tumour Immunology Perth Australia
Aldehyde-mannose preferentially localises to Class I pathway and Unusual features of MUC1 peptide presentation.

Main Speaker (invited). Peptide Users Group Royal Australian Chemical Institute, Autumn Symposium - CSIRO Division of Biomolecular Engineering, Melbourne, VIC, Australia
Peptide mimics for cancer therapy

Speaker. 5th Conference Immunology Group of Victoria - New directions in immunological research, Mt Buffalo, VIC, Australia
Mannan-MUC1 peptides presented in a novel class I manner and a MUC1 mimic induces functional CTLs


1996

Speaker (invited). 2nd Curtin Conference-Cytokines and the Immune Response, Canberra, Australia
Cancer vaccine studies using mannan-fusion protein (MFP) and cytokines. 

Speaker (invited). 4th International Workshop on Cancer Associated Mucins, Cambridge, England
Enhancing MUC1 Immunogenicity and its potential as a cancer vaccine

Speaker. Austin Hospital Research Week, Repatriation Campus, Heidelberg, VIC, Australia
Novel Strategies for Cancer Vaccination

Speaker. 1st Congress of The Federation of Immunological Societies of Oceana. Adelaide, Australia
The induction of CTL using M-FP: detection of multiple MUC1 epitopes which associate with Class I molecules in a novel manner 

Tumour Immunology Workshop Speaker. 1st Daydream Island. Queensland, Australia
Immunogenicity of mannan-MUC1 peptides: novel Class I peptide presentation and strategies to enhance the immunogenicity


1995

Speaker. 7th Lorne Cancer Conference. Lorne, Australia
Immunotherapy for breast cancer using a carbohydrate antigen conjugate.

Speaker. Cambridge Healthtech Institute Conference. Cancer Vaccines. Virginia, USA
Differential Immunisation to induce TH1 or TH2 Immune Responses for Cancer Vaccines. 

Speaker. 4th Annual Meeting of The Immunology Group of Victoria. WEHI, Melbourne, Australia
Analysis of the Immune Responses Generated by Mice Immunised with Mannan-Fusion Protein.

Speaker. 4th International Conference - Gene Therapy and Cancer. San Diego, California, USA
Mannan MUC1-Fusion Protein and Gene Therapy. 

Speaker. 25th Australasian Society for Immunology Inc., Gold Coast, Queensland, Australia
Analysis of the Immune Responses in mice immunised with MFP.


1994

Symposium Speaker. NATO Advanced Studies Institute. Vaccines: New-Generation Immunological Adjuvants. Cape Sounion Beach, Greece
Differential Immunisation to induce humoral and cellular immunity for cancer vaccines.

Workshop Speaker. 33rd National Scientific Conference, Australian Society for Medical Research. Melbourne, Australia
Is a breast cancer vaccine feasible? 

ASI 'Young Investigator Award' Session Speaker. 24th Annual Scientific Meeting, The Australasian Society for Immunology Inc., Australian National University, Canberra, Australia
Differential Immunisation to induce TH1 or TH2 immune responses.


1993

Symposia Speaker. Australia/New Zealand breast cancer trials group studies - New Research Session. 20th Annual Scientific meeting of the Clinical Oncological Society of Australia (COSA). Perth, Australia
Use of synthetic peptides to immunise against breast cancer.  

Symposia Speaker. Novel molecular strategies for tumour regression - Cancer Research Session. 20th Annual Scientific meeting of the Clinical Oncological Society of Australia (COSA). Perth, Australia
Synthetic mucin peptides as T cell epitopes in cancer.  

Symposia Speaker. Tumour Biology & NK cells. Australian Society of Immunology, Sydney Australia
Is a breast cancer vaccine feasible?

Workshop Speaker. Tumour Biology. Australasian Society for Immunology. Sydney, Australia
Use of synthetic peptides to immunise against breast cancer. 


1992

Keynote Speaker (invited). Australian Institute of Medical Scientists, Bairnsdale, Australia
New monoclonal antibodies reactive with mucins expressed in breast cancer. 

Workshop Speaker. 36th Australian Society for Biochemistry and Molecular Biology Conference, Melbourne, Australia
Second generation MUC3 peptide monoclonal antibodies reactive with colon cancer.

Speaker. 1st Immunology group of Victoria. WEHI, VIC, Australia
i) 2nd generation monoclonal antibodies to intestinal Mucin 3
ii) Immunotherapy for Breast Cancer. 

Workshop Speaker. 22nd Annual Meeting, Australian Society for Immunology, Auckland, New Zealand
i) Second generation monoclonal antibodies to intestinal Mucin 3
ii) Immunotherapy for Breast Cancer. 


1991

Workshop Speaker. 21st Annual Meeting, Australian Society for Immunology, Perth, Australia
Monoclonal antibodies reactive with mucins expressed in breast cancer. 





SCIENTIFIC SEMINARS / PUBLIC LECTURES

2014

Speaker (invited). Biomedical and Lifestyle Diseases (BioLED) Research Unit, Victoria University, VIC Australia.
Immunotherapy in the last 20 years, what have we learnt

Speaker (invited). Western Centre for Health Research and Education (WCHRE), Sunshine Hospital VIC Australia
Research, technologies and new collaborations

Speaker (invited). Institute of Sport Exercise and Active Living (ISEAL), Victoria University Footscray Campus, VIC Australia.
Exercise and Immunology: their importance in health and disease


Invited Speaker (invited, accepted). Western Buddies Breast Cancer Support Group. ISIS Primary Care, Melbourne, VIC Australia.
Development of a breast cancer vaccine: what have we learnt in the last 20 years.


2011

Guest Speaker (invited). Ballarat Pink Phoenix, Seymours Hotel, Ballarat, VIC, Australia.
Development of a breast cancer vaccine, how far are we…..

Guest Speaker (invited). Pink Ribbon Breakfast. Kids Resort Early Learning Centre, Sanctuary Lakes, VIC, Australia.
Breast cancer research 


2010

Guest Speaker (invited). West Cancer Support Group. St Phillips Uniting Church, Airport West, VIC, Australia.
Cancer Research - Past, Present and Future

Guest Speaker (invited). Pink Ribbon Breakfast. Kids Resort Early Learning Centre, Sanctuary Lakes, VIC, Australia.
Breast cancer research – a vaccine within sight?


2009

Special Guest Lecture (invited). ISIS Primary Care, Breast Cancer Support Group. Altona Meadows, VIC Australia
Breast cancer research: updates and developments

Special Guest Speaker (invited). Afternoon Tea Fundraiser in memory of Angela’s Smile. Mount Waverly, VIC Australia
Breast cancer: Research and developments

Special Guest Lecture (invited). Hellenic Women’s Cultural Association, in association with Pink Ribbon Day and Cancer Council Victoria. Oakleigh, VIC Australia
Breast cancer research: updates and developments

Invited Speaker, Institute Seminar Series (invited). Department of Immunology, Monash University, Prahran, VIC Australia
Immunotherapy of multiple sclerosis using altered peptide ligands and reduced mannan

Invited Speaker, Institute Seminar Series (invited). Department of Immunology, Monash University, Prahran, VIC Australia
Non-canonical peptides bound to MHC: implications in vaccine design


2008

Special Guest Lecture (invited). The Williamstown-Point Gellibrand Ladies Probus Club. Williamstown, VIC Australia
Cancer research and development of cancer vaccines

Guest Speaker (invited). Brimbank Central Rotary Club, VIC Australia
How far are we of a cancer vaccine

Special Guest Lecture (invited). The Ladies Probus Club of Jells Park. VIC Australia
Development of a vaccine against breast cancer

Speaker. Infectious diseases and cancer vaccines program, Burnet Institute, Prahran, VIC Australia
Update on immunotherapy of cancer projects in the lab

Speaker. Burnet Institute Retreat, Stonelea Country Estate, VIC Australia
Methods of immunotherapy for cancer and multiple sclerosis

Guest Speaker (invited). National Breast Cancer Day, Fundraiser, Sanctuary Lakes, VIC Australia.
Breast cancer research – where is it heading

Guest Lecture (invited). Victoria University, Human Biomedical Sciences, 2nd Year Pathology Nursing Students, St Albans Campus, VIC Australia
Neoplasia (4 Lectures)


2007

Special Guest Lecture (invited). Bodossaki Foundation Seminar Series of outstanding scientists. University of Patras Conference Center. Patras, Greece. 
Cancer Immunotherapy program over the last 15 years: what have we learnt, where are going?

Discussions (invited). Prolipsis Medical Center. Athens, Greece.
Phase III clinical trial: vaccine production and update on patient responses. Application to EORTC

Discussions (invited). ELPEN SA Pharmaceuticals. Athens, Greece.
MUC1 and clinical trials: from bench to bedside

Invited Speaker. Burnet Institute Austin Campus. Heidelberg, VIC Australia. 
Novel modes of peptide binding to MHC class I: Implications in peptide-based vaccine design

Invited. Member of the panel and Panel Speaker. Food for thought: Greek Australian Women’s Network, VIC Australia
Breast and Ovarian cancer 

Internal Seminar Series Speaker. Diamantina Institute for Cancer, Immunology and Metabolic Medicine, Princess Alexandra Hospital, University of Queensland, Australia
Non-canonical peptides in complex with MHC class I or II: are we seeing the whole picture 

Guest Lecture. Victoria University, Human Biomedical Sciences, 2nd Year Pathology Nursing Students, St Albans VIC Australia
Neoplasia (4 Lectures)

Special Guest Lecture (invited). Australian Greek Society for the care of the Elderly ‘Frondida’ St Albans –campus, Brunswick Patras House, VIC Australia.
Cancer vaccines: from bench to bedside


2006

Guest Lecture.  RMIT University Master in Biotechnology Students. City Campus, VIC, Australia.
Peptide-MHC interactions

Guest Lecture. RMIT University Master in Biotechnology Students. City Campus, VIC, Australia.
Cancer and Vaccines.

Guest Lecture. Victoria University, 3rd Year Science Students. School of Molecular Sciences, VIC, Australia.
Crystallography.

Invited Speaker. Burnet Institute-Monash Immunology joint seminar series. AMREP, Melbourne, VIC Australia
Novel modes of peptide binding to MHC class I: Implications in peptide-based vaccine design

Invited Speaker. MacFarlane Burnet Institute for Medical Research and Public Health, Board meeting. Melbourne, VIC Australia.
Immunology and vaccine laboratory research update

Speaker. Equity Trustee, Melbourne, VIC Australia.
Development of new improved cancer vaccines – mannan-DNA

Laboratory Presentation Dr Labcoat. Burnet Institute, Austin Campus, Heidelberg, VIC Australia.
Experimental presentations to Year 8 students from Samaratan Catholic College. SDS-PAGE gels, ELISA, crystallography, tissue culture, FPLC, etc


2005

Invited Speaker. Chemistry and Biology Seminar Series. Deakin University, School of Biological & Chemical Science, Geelong, VIC Australia.
A membrane translocating peptide from Antennapedia induces cellular responses to cancer proteins

Invited Speaker. Brisbane Immunology Seminar Series. Queensland Institute of Medical Research, Brisbane, QLD Australia.
Novel delivery methods for inducing immunity to proteins and DNA: Int Vs Mannan

Invited Speaker. Mater Medical Research Institute, South Brisbane, Queensland, Australia.
Novel delivery methods for inducing immunity to proteins and DNA: Int Vs Mannan

Invited Guest Speaker, Breakfast. Zonta Club of Melbourne CBD, Melbourne, VIC Australia.
Cancer vaccines: where are we, what are we doing, where are we going

Invited Speaker. Chemistry-Biology Seminar Series. Deakin University, School of Biological & Chemical Science, Geelong, VIC Australia.
Cyclic peptides: use in multiple sclerosis

Invited Speaker. Tumour Immunity Medical Research Center, Cancer Research Institute, Seoul, Korea.
Novel modes of peptide binding to MHC class I: Implications in peptide-based vaccine design

Invited Guest Speaker. International Woman’s Day. Women’s Committee of the Zonta Club of Bendigo, Bendigo, VIC Australia.
Cancer vaccines: where are we, what are we doing, where are we going

Guest Lecture. RMIT University Master in Biotechnology Students. City Campus, VIC, Australia.
Peptide-MHC interactions

Guest Lecture. RMIT University Master in Biotechnology Students. City Campus, VIC, Australia.
Cancer and Vaccines.

Invited Speaker. Loreto College, Toorak, VIC Australia. (Year 12 Health and Human Development students: talk as part of their subject, and exam will be taken specifically on the talk).
Breast cancer: is a vaccine around the corner? 

Speaker. State Trustees Australia Foundation, VIC Australia.
Development of new improved cancer vaccines

Invited Speaker. Veterans Community Forum, Austin Health (Repatriation campus), Heidelberg, VIC Australia.
Cancer vaccines: where are we heading

Speaker. Burnet Institute for Medical Research, Prahran, VIC Australia
Cancer vaccines program at the Austin Research Institute

Laboratory Presentation - National Science Week, Project Labcoat. The Austin Research Institute, Heidelberg, VIC Australia.
Experimental presentations to Year 10 and 11 students from Catholic Ladies College and MacLeod Secondary College. SDS-PAGE, ELISA, crystallography, tissue culture etc


2004

Invited Guest Speaker. Australian Breast Cancer Day. Austin Hospital, Heidelberg VIC Australia.
How far are we from a breast cancer vaccine?

Invited Speaker. Chemistry and Biology Seminar Series. Deakin University, School of Biological & Chemical Science, Geelong, VIC Australia.
Cancer vaccines: From animal models, to x-ray crystallography, to human clinical trials

Invited Speaker. Prince Henry’s Institute of Medical Research, VIC Australia.
Cancer vaccines: From animal models, to x-ray crystallography, to human clinical trials

Invited Speaker. Seoul National University College of Medicine, Seoul, Korea (could not attend)
Novel modes of peptide binding to MHC class I: Implications in peptide-based vaccine design

Guest Speaker. Rotary Club of Port Arlington, VIC Australia
How far are we of a cancer vaccine

Guest Lecture. RMIT University Master in Biotechnology Students. City Campus, VIC, Australia.
Peptide-MHC interactions

Guest Lecture. RMIT University Master in Biotechnology Students. City Campus, VIC, Australia.
Cancer and Vaccines.

Invited Speaker. Department of Microbiology, University of Melbourne, VIC Australia.
Novel modes of peptide binding to MHC class I 

Invited Speaker. University of Ioannina, Department of Chemistry, Ioannina, Greece.
Clinical trials using mannan-MUC1

Invited Speaker. University of Athens, Department of Pharmacy, Athens, Greece.
Clinical trials using mannan-MUC1

Discussions. ELPEN A.E Pharmaceuticals, Athens, Greece
i) Oxidised mannan-MUC1 in patients with adenocarcinoma
ii) Medical Research in Greece and Abroad

Special Seminar Speaker. Torrey Pines Institute for Molecular Studies, La Jolla, California, USA
Non-canonical peptides bound to MHC class I molecules: Use of peptide libraries

Speaker. The Scripps Research Institute, Department of Molecular Biology, La Jolla, CA, USA
Non-canonical peptides bound to MHC class I molecules: Our collaborative projects update

Invited Speaker. Austin Research Institute, Board meeting. Heidelberg, VIC Australia.
Immunology and vaccine laboratory research update


2003

Guest Lecture. RMIT 3rd Year Science Students, Immunology Lecture Series. Bundoora Campus, VIC Australia
Cancer and Vaccines.

Guest Speaker. Rotary Club of Rowville, VIC Australia
How far are we with a cancer vaccine

Guest Speaker. Austin Breast Cancer Foundation. Melbourne, VIC, Australia
Development of a vaccine for cancer: Where are we.

Guest Lecture. RMIT Master in Biotechnology Students. City Campus, VIC, Australia
Cancer Vaccines.

Invited Speaker. Ludwig Institute for Cancer Research. Parkville Campus, Melbourne, VIC, Australia
i) Crystal structures of MHC class I with non-canonical peptides: Implications in vaccine design
ii) Pilot Phase III clinical trial: immunological responses, clinical outcomes and breaking of the code

Invited Speaker. Bodossaki Foundation. Athens, Greece.
Development of a vaccine for breast cancer: outcomes

Special Seminar Speaker. Centre for Immunology and Cancer Research, Princess Alexandra Hospital, Brisbane, QLD, Australia
Clinical trials using mannan-MUC1 and mannan-MUC1 pulsed dendritic cells

Special Seminar Speaker. Mater Misericordiae Hospital, South Brisbane, Queensland, Australia
Immunotherapy using dendritic cells pulsed with mannan-MUC1

Immunology Seminar Series Speaker. Queensland Institute of Medical Research, Brisbane, Qld Australia
Clinical trial using mannan-MUC1 and mannan-MUC1-dendritic cells

Immunology Seminar Series Speaker. Queensland Institute of Medical Research, Brisbane, Qld Australia
Crystal structures of MHC class I with unusual peptides: Implications in peptide based vaccine design

Special Seminar Speaker. Mater Medical Research Institute, South Brisbane, Queensland, Australia
Crystal structures of MHC class I with unusual peptides: Implications in peptide based vaccine design

Guest Speaker. Greek Orthodox Community of South Australia, Adelaide, Australia
Cancer Research - Past, Present and Future


2002

Invited Speaker. Ludwig Institute for Medical Research. Austin Campus, VIC Australia.
Immunotherapy of patients immunised with dendritic cells pulsed with mannan-MUC1

Discussions. Prolipsis Medical Center. Athens, Greece.
Pilot Phase III clinical trial: progress

Guest Speaker. National Science Week: Hot-Air Balloon Launch, Orbost, VIC Australia.
Presentation as being the current Victorian Tall Poppy

Invited Speaker. National Science Week: Orbost Primary School, Orbost, VIC Australia.
Presentation to primary school kids (grades 3-6), about research, science and cancer, as being the current Victorian Tall Poppy

Invited Speaker. National Science Week: Orbost Secondary College, Orbost, VIC Australia.
Presentation to high school kids (years 7-12), about research, science and cancer, as being the current Victorian Tall Poppy

Guest Speaker. Rotary Club of Orbost - on the Snowy River, Orbost, VIC Australia.
Updates on Cancer research. Presentation as being the current Victorian Tall Poppy

Invited Speaker. National Cancer Week: Banyule Breast Cancer Support Group. Rosanna, VIC, Australia.
Cancer Research - Yesterday, today and tomorrow….

Guest Lecture. RMIT 3rd Year Science Students, Immunology Lecture Series. Bundoora Campus, VIC Australia
Cancer and Vaccines.


2001

Guest Speaker. West Cancer Support Group. St Phillips Uniting Church, Airport West, VIC, Australia.
Cancer Research - Past, Present and Future

Speaker. The Scripps Research Institute, Department of Molecular Biology, La Jolla, CA, USA
Crystal structures non-canonical peptide-MHC complexes: update


2000

Invited Speaker. Mayo Clinic, Dept of Biochemistry & Molecular Biology. Scottsdale, Arizona, USA.
MUC1 immune responses: what we have learnt about MHC-class I peptide binding

Special Seminar Speaker. The Scripps Research Institute, Dept of Immunology, La Jolla, CA, USA
Immunotherapy in mice using MUC1 antigens

Invited Speaker. Washington State Univ. Dept Vet. Microbiology/Pathology, Pullman, WA, USA.
Role of the mannose receptor in the immune response

Invited Speaker. University of Washington, Dept Medicinal Chemistry, Seattle, WA, USA.
Crystal structure of an immunogenic peptide-MHC complex with a non-canonical low affinity peptide

Speaker. The Scripps Research Institute, Department of Molecular Biology, La Jolla, CA, USA
Crystal structure of an immunogenic peptide-MHC complex with a non-canonical low affinity peptide

Invited Guest Speaker. Disability Management Employer Coalition. Long Beach, CA, USA
A cancer vaccine: How far are we?

Discussions. Prolipsis Medical Center. Athens, Greece.
Pilot Phase III clinical trial: progress


1999

Guest Speaker. Assumption of Blessed Virgin Mary, Long Beach, CA USA
Towards the development of a cancer vaccine, how far are we


1998

Special Guest Speaker (invited). Cyprian Medical Association, International Conference Center, Nicosia Cyprus.
Clinical results of Phase I/II and proposed Phase III trials

Special Guest Speaker (invited). Ministry of Health - Cyprian Medical Association. Nicosia Cyprus. Lecture given in Greek to the public (Host: Minister of Health of Cyprus, Mr Christos Solomis).
Is a Breast cancer vaccine within sight?

Invited Speaker. Cyprus Institute of Neurology and Genetics, Nicosia Cyprus.
Mannan mediated delivery for the induction of MUC1 specific T1/T2 immune responses 

Speaker. The Scripps Research Institute, Department of Immunology, La Jolla, CA, USA
Oxidised Mannose Delivers Peptides Into the Class I MHC Presentation Pathway

Special Seminar Speaker. University of Massachusetts Medical Center, Department of Pathology, Worcester, MA USA
Aldehyde - mannan antigen complexes preferentially target the MHC Class I pathway 

Invited Speaker. University of Oxford, Sir William Dunn School of Pathology, Oxford, England.
Aldehyde - mannan antigen complexes preferentially target the MHC Class I pathway

Invited Speaker. Wyeth-Ayerst Research, Malvern, Philadelphia, PA, USA.
Role of aldehydes in MHC Class I peptide presentation

Invited Guest Speaker. Axion Foundation. St Paul’s Greek Orthodox Church, Irvine, CA, USA
Cancer Research: Past, Present and Future

Invited Guest Speaker. Greek Business Club. San Diego, CA, USA
A vaccine for cancer: how far are we?

Invited Guest Speaker. Committees of Greek Australian Patreans in Athens, Athens conference center, Athens, Greece. Lecture given in Greek to the public.
A vaccine for cancer: how far are we?

Invited Guest Speaker. Committees of Greek Australians, Patreans in Athens, Patras conference center, Patras, Greece. Lecture given in Greek to the public.
A vaccine for cancer: how far are we?

Invited Speaker. University of Patras, Department of Chemistry, Patras, Greece
Peptide mimics for tumour immunotherapy and results of preclinical and clinical trials

Guest Lecture. University of Patras, Department of Chemistry, Patras, Greece
Cancer immunotherapy using peptide complexes

Invited Speaker. National University of Athens, Department of Pathophysiology, Athens, Greece
Novel peptide binding for MHC-Class I molecules

Discussions. Prolipsis Medical Center. Board meeting, Athens, Greece.
Pilot Phase III clinical trial: an update


1997

Special Seminar Speaker. Eberhard-Karls-Universitat Tubingen, Institute for Cell Biology, Abteilung Immunologie, Tubingen, Germany.
Unusual features of MUC1 peptide presentation to Class I molecules.

Invited Guest Speaker. Ministry of Health and Hellenic Cancer Society, Hilton, Athens Greece.
Clinical results of Phase I/II and proposed Phase III trials

Discussions. Prolipsis Medical Center. Board meeting, Athens, Greece.
Pilot Phase III clinical trial: proposal

Invited Speaker. Department of Tumour Cell Biology, Danish Cancer Society, Copenhagen, Denmark.
Immunogenicity of mannan-MUC1 peptides

Invited Speaker. University of Aarhus, Dept of Medical Microbiology/Immunology, Aarhus, Denmark.
Cell-mediated immune responses to MUC1, a marker for cancer.

Invited Speaker. US Department of Agriculture, Plum Island Animal Disease Center, Plum Island, Connecticut USA
Mannan as an adjuvant for immunotherapy

Special Seminar Speaker. National Institute of Health, Lab of Viral Diseases, Bethesda, Maryland, USA
Unusual features of MUC1 peptide presentation to Class I molecules.

Special Seminar Speaker. Institute of Pathology, Case Western Reserve Univ., Cleveland, OH, USA
Aldehyde-mannose preferentially localises to Class I pathway.

Speaker. The Scripps Research Institute, Dept Molecular Biology, La Jolla, CA, USA
Unusual features of MUC1 peptide presentation to Class I molecules.

Special Seminar Speaker. Torrey Pines Institute for Molecular Studies, San Diego, California USA
Immunogenicity of mannan-MUC1 peptides for tumour immunotherapy

Invited Speaker. Prince Henry's Institute of Medical Research, Monash Medical Center, Clayton, VIC Australia
Antigen presentation in the design of a tumour vaccine

Invited Speaker. Ludwig Institute for Cancer Research, Austin Hospital, Heidelberg, VIC Australia
MUC1 as a target for Immunotherapy

Invited Guest Speaker. EEAMA League of Greeks from Egypt and the Middle East. Melbourne, VIC Australia. Lecture in Greek
A cancer vaccine within sight?

Public Lecture. Austin Research Institute Medical Research Week. Heidelberg, VIC Australia
Is a Breast Cancer Vaccine within sight? 

Invited Speaker. Western Hospital - Sunshine, Gynecological Ward, VIC, Australia
A cancer vaccine within sight?

Invited Speaker. The Austin Breast Cancer Foundation's - Look of the 21st Century. The Austin Research Institute, Heidelberg, VIC, Australia
Breast Cancer Research

Invited Guest Speaker. St. Kilda Rotary Club, Melbourne, Australia
Breast Cancer Vaccine Research at the ARI

Invited Guest Speaker. Rotary Club of Malvern, Melbourne, Australia
Cancer Research at the ARI

Invited Guest Speaker. PanCretan Community of Melbourne and Victoria. Cretan Village, Melbourne, Australia. Lecture in Greek
Breast Cancer Research; past present and future


1996

Special Seminar Speaker. John Curtin School of Medical Research, Division of Immunology and Cell Biology, Canberra, Australia
Novel Approaches to Tumour Vaccines

Special Seminar Speaker. University of Oxford, Sir William Dunn School of Pathology, Oxford, England
Mannan-MUC1 for Immunotherapy of Breast Cancer

​Seminar Speaker. Institute of Molecular Medicine, Molecular Immunology Group, John Radcliffe Hospital, Oxford, England
Mannan-antigen induces Th1 responses in mice

Invited Speaker. The Edward Jenner Institute for Vaccine Research / Dept of Immunology, University College, London, England
Immunotherapy of Breast Cancer using Mannan-MUC1 Conjugates

​Speaker. Imperial College London, London, England
Cellular responses to MUC1 antigen

Special Seminar Speaker. Netherlands Cancer Institute, Antoni van Leeuwenhoekhuis, Department of Tumour Biology, Amsterdam.
The use of mannan conjugates with MUC1 for tumour therapy

Special Seminar Speaker. University of Leiden, Dept of Immunohematology, Academisch Ziekenhuis, Leiden, The Netherlands 
Mannan-MUC1 Conjugates for immunotherapy

Invited Speaker. St. Vincent's Institute of Medical Research, Melbourne, VIC, Australia
A novel strategy in the development of a breast cancer vaccine

Invited Speaker. Ludwig Institute for Cancer Research, Royal Melbourne Hospital, VIC Australia
Novel Strategies for Cancer Vaccination

Speaker. The Sir Edward Dunlop Medical Research Foundation - presentation to the members. The Austin Research Institute, Heidelberg, VIC, Australia
Breast/colon/prostate cancer vaccine development


​1995

Special Seminar Speaker. University of Pittsburgh, School of Medicine, Dept Molecular Genetics & Biochem, Pennsylvania, USA
MUC1 peptides for Immunotherapy. 

Special Seminar Speaker. Howard Hughes Medical Institute, Rockefeller University, New York, USA
Oxidised versus Reduced Mannan as a protein carrier - ? Mode of Action.

Ph.D. Oration. The Austin Research Institute, Heidelberg, Victoria, Australia
Immunotherapy of Cancer using Mucin (MUC1) Antigens.


1994

Young Researcher Presentation. The Victorian Society of Pathology and Experimental Medicine and The Australian Society for Medical Research - Peter MacCallum Hospital, VIC, Australia, (Finalist in the VSPEM-ASMR Student Award).
Is a breast cancer vaccine feasible?  

Invited Speaker. Alfred Medical School, Alfred Hospital, VIC Australia.
Mucins as targets for immunotherapy.  

Invited Guest Speaker. Cypriot Community of Melbourne, Australia. Lecture given in Greek
Breast Cancer - History, treatments and 'potential vaccine'. 

Invited Guest Speaker. Glenferrie Rotary Club. Melbourne, Australia.
The development of a Breast Cancer Vaccine.


1993

Invited Guest Speaker. Asclepius Committee, Melbourne, Australia. Lecture given in Greek
Breast cancer vaccine: is it possible.  





NON-SCIENTIFIC PRESENTATIONS

2014

Welcome Address (invited). 2nd National Conference of the Peloponnese: Developmental Prospects for Western Greece. Porto Rio Hotel, Rio, Greece
Where is Greece heading, what needs to be done


​2011

Invited Speaker. Westbourne Grammar School, Williamstown, Melbourne, VIC Australia
I am a Scientist. Presentation and Demonstration to Year Prep students about life as a scientist


2009

Invited Speaker. Bosom Buddies Breast Cancer Foundation Charity Golf Day. Kingston Heath golf club, VIC Australia
Update on our Breast cancer research


2008

Australia Day Ambassador Address (invited). Apollo Bay, VIC Australia
Address for Australia Day and Award presentations

Guest Speaker (invited). Careers Week. St Johns College, Preston VIC Australia
Achievement and Setting Goals [Speech to Yr 10-12 students]

Invited Address. St Johns College, Preston, VIC Australia
Address to Year 12 Students: life after high school and achievement


2007

Australia Day Ambassador Address. Koo Wee Rup, Regional Victoria, VIC Australia
Address for Australia Day, Flag raising and Award presentations

Invited Speaker. Austin Breast Cancer Foundation Charity Golf Day. Kingston Heath golf club, VIC Australia
Update on our Breast cancer research

Talk. Bosom Buddies Committee Meeting, Melbourne, VIC Australia
Breast cancer research, update on current projects

Opening Remarks. Women’s Wellness in the West Forum. Victoria University, VIC Australia
Women’s health network in the West: what is it all about

Invited Guest Speaker. Austin Breast Cancer Foundation Golf Day. Lakelands golf club, Gold Coast, Queensland Australia
Breast cancer research at the Burnet Institute

Invited Keynote Address (invited). Braybrook College, Victoria University, Footscray campus, VIC Australia
Address to Year 12 graduating students: education in the west and career development 


2006

Launch. Victorian Honor Roll of Women for 2007. National Gallery of Australia, VIC Australia
One of 5 women high achievers to launch the call for nominations for 2007 (Dame Elisabeth Murdoch, Christine Nixon, Bridgette Muir, Cathy Freeman, Vasso Apostolopoulos).


2005

Australia Day Ambassador Address. Stawell, Northern Grampians Shire, VIC Australia.
Address for Australia Day, Flag raising and Award presentations

Invited Speaker. Back to School Program, Education Foundation of Victoria. Copperfield College, VIC Australia
Life after High school - what to expect and how to achieve and set goals [Yr 12 students].

Speaker. Harness Racing - Austin Breast Cancer Foundation. Moonee Valley Racecourse, VIC, Australia
What is the foundation, who are we, what do we do


2004

Invited Address. MacKillop Secondary College, Werribee, VIC Australia
Address to High School Students at the Annual Speech night to the College and award presentations

Invited Address. Copperfield Secondary College, Delahey, VIC Australia
Address to Year 12 Students and presentation of awards to outstanding students

Invited Guest Speaker. Achievement 2004. Workshop for Personal and Business Development. Hemisphere Conference Center, Moorabbin VIC, Australia
Winning Performance and You

Speaker. Harness Racing - Austin Breast Cancer Foundation Fundraiser. Moonee Valley Racecourse, VIC, Australia
What is the foundation, who are we, what do we do

Occasional Address. Victoria University - Faculty of Science, Engineering and Technology - Graduation Ceremony. Melbourne Convention Center, VIC Australia
‘Occasional Address’ to the graduating students

Invited. Panel Member and Speaker. Western Melbourne Opportunity Summit, Mansion Hotel, Werribee VIC Australia
'Hypothetical Session' focused around regional development

Address. Women of the year 2003. Athens, Greece
What is it like being - Women of the year


2001

Invited Guest Speaker. Western Melbourne Opportunity Summit, Victoria University Convention Centre, VIC Australia
Growing up in the West

Invited Guest Speaker. Western Melbourne Regional Economic Development Organisation (WREDO), Networking Breakfast, The Pumping Station, Scienceworks, Melbourne, Australia
Research at the Austin Research Institute


1999

VIP Honorary Guest Speaker. North American Youth Convention of SAE, Chicago USA
Who we were, Who we are, Where are we going

Invited Guest Speaker. American Business Convention. San Diego, CA, USA
Business development and achieving


1998

Invited Guest Speaker. Hellenic American Women’s Council. Pacific Coast Region. Women of Substance Conference. Layola Marymount University, Los Angeles, CA USA
Achieving and being a Greek-Australian woman

VIP Honorary Guest Speaker. 2nd International Pan-Iliako Conference, Olympia, Greece
Can Research be done in Greece? Problems and Proposals

Guest Speaker. International Day of Women. Greek Welfare Center of Australia. Melbourne, Australia
The bridge between generations 

Guest Speaker. 7th National Youth Conference, Greek Archdiocese of Australia. Sydney, Australia
Faith: A power beyond the humane

Launch and Speaker. Launch - New Idea Breast Cancer Fund. Sheraton Towers, Melbourne, Australia
Speech on the importance of the fund for Breast Cancer Research


1997

Honorary Committee Member and Panel Speaker. First convention of the World Council for Hellenes Abroad. Thessalonica, Greece
Younger Generation of Diaspora Greeks: Problems and Proposals

Invited Guest Speaker. Achievement 97, Workshop for Personal and Business Development; Lecture on achieving as being the Young Achiever of the Year, LaTrobe University, VIC, Australia.
Winning Performance and You

Launch and Speaker. Launch - 1998 Young Australian of the Year Awards, Victorian Launch. Melbourne Hilton on the Park, Melbourne, Australia.
Speech as being the Current Young Achiever of the Year

Launch and Speaker. Launch - Get a Life Magazine for young school leavers. Produced by the Office of Fair Trading and Business Affairs, and Network Channel 10. Hoyt’s Cinema - Melbourne, Australia.
Inspiring words to the Young Audience as being The Young Achiever of the Year







LINKS

1998, 2nd PanIliako Conference
Ancient Olympia, Greece
1998, Launch, Australian of the Year Awards
1998, Guest Speaker, Hilton Hotel Athens Greece
1999, Meeting in Greece
2005, Plenary Lecture, 14th Cancer Institute Symposium, Seoul Korea
2005, Austin Research Institute, Business Breakfast